Susan L. Cohn to Receptors, KIR2DL1
This is a "connection" page, showing publications Susan L. Cohn has written about Receptors, KIR2DL1.
Connection Strength
0.040
-
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clin Cancer Res. 2018 01 01; 24(1):189-196.
Score: 0.040